Clovis Oncology Inc (CLVS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5500 FLATIRON PARKWAY BOULDER, CO 80301

Clovis Oncology, Inc. develops and commercializes anti-cancer pharmaceutical drugs. The company develops CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine, which is in Phase III clinical trials for first-line treatment of metastatic pancreatic cancer; Phase II clinical trials for second-line treatment of metastatic pancreatic cancer; and preclinical trials for solid tumors. Its products also include CO-1686, a small molecule epidermal growth factor receptor, which is in preclinical trials for the treatment of non-small cell lung cancer; and CO-338, a small molecule PARP inhibitor, which is in Phase II clinical trials for the adjuvant treatment of hereditary, or germ-line, BRCA mutant, and triple-negative breast cancer, as well as Phase I clinical trials for the treatment of solid tumors. The company intends to sell its products through distributors in the United States, Europe, and internationally. Clovis Oncology, Inc. was founded in 2009 and is based in Boulder, Colorado.

Data as of 2021-05-08 11:10:16 -0400
Market Cap589.746 Million Shares Outstanding104.565 Million Avg 30-day Volume3.993 Million
P/E Ratio-1.75438 Dividend Yield EPS-3.64
Price/Sales3.69 Debt to Equity-2.48 EBITDA-272.879 Million
Price to Book Value-2.67 Forward PE-2.13 Enterprise Value1.027 Billion
Total Cash190.922 Million Current Debt173.236 Million Gross Profit124.711 Million
BETA1.1272 52-week High/Low11.1 / 4.08 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from CLVS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 2 -100.0% 0 (0.0%) 2 (0.12%) -100.0%
Funds Holding: 158 169 -6.51% 43 (2.58%) 40 (2.49%) 7.5%
13F shares: 55.071 Million 51.133 Million 7.7% 18.585 Million 18.739 Million -0.82%
% Ownership 53.2442 57.8962 -8.04% 17.9681 21.2173 -15.31%
New Positions: 25 32 -21.88% 10 7 42.86%
Increased Positions 50 55 -9.09% 15 15 0.0%
Closed Positions 35 20 75.0% 7 8 -12.5%
Reduced Positions 44 42 4.76% 11 13 -15.38%
Total Calls 3.935 Million 5.059 Million -22.21% 1.048 Million 2.516 Million -58.35%
Total Puts 5.391 Million 4.452 Million 21.08% 1.189 Million 1.181 Million 0.67%
PUT/CALL Ratio 1.37 0.88 55.68% 1.13 0.47 140.43%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

20 Thousand total shares from 13 transactions

Exercise Derivative Conversion (M)

40.8 Thousand total shares from 13 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

IVERS-READ GILLIAN C SEE REMARKS

  • Officer
1,074,192 2021-05-01 12

ROLFE LINDSEY SEE REMARKS

  • Officer
370,291 2021-05-01 12

MUEHL DANIEL W SEE REMARKS

  • Officer
415,765 2021-05-01 10

GROSS PAUL EDWARD SEE REMARKS

  • Officer
377,306 2021-05-01 8

HARDING THOMAS C. SEE REMARKS

  • Officer
41,805 2021-05-01 9

MAHAFFY PATRICK J SEE REMARKS

  • Officer
  • Director
380,000 2021-03-01 1

ATWOOD BRIAN G

  • Director
160,190 2020-11-09 2

SPICKSCHEN THORLEF

  • Director
0 2020-06-04 1

MCKINLEY EDWARD J

  • Director
0 2020-06-04 1

BLAIR JAMES C

  • Director
0 2020-06-04 1

KLINGENSTEIN PAUL H

  • Director
0 2020-06-04 1

FLAHERTY KEITH T.

  • Director
0 2020-06-04 1

GRAHAM GINGER L

  • Director
0 2020-06-04 1

FAIR RICHARD A.

  • Director
0 2020-06-04 1

AZELBY ROBERT

  • Director
0 2020-06-04 1

BARRETT M JAMES

  • Director
0 2018-10-11 0

FAIR RICHARD A.

FAIR RICHARD A.

  • Director
0 2018-10-11 1

HOOKS CORWIN DALE SEE REMARKS

  • Officer
5,349 2018-09-05 0

MAST ERLE T EXECUTIVE VP AND CFO

  • Officer
135,583 2015-11-02 0

HOERTER STEVEN L. SEE REMARKS

  • Officer
0 2015-03-05 0

ALLEN ANDREW R SEE REMARKS

  • Officer
0 2015-03-02 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
44,034 2013-06-04 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

SCHOEMAKER KATHLEEN K

  • Director
  • 10% Owner
2,581,745 2013-06-04 0

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
No longer subject to file 2013-06-03 0

BARRIS PETER J

  • 10% Owner
No longer subject to file 2013-06-03 0

KOLLURI KRISHNA KITTU

  • 10% Owner
No longer subject to file 2013-06-03 0

KERINS PATRICK J

  • 10% Owner
No longer subject to file 2013-06-03 0

DRANT RYAN D

  • 10% Owner
No longer subject to file 2013-06-03 0

BASKETT FOREST

  • 10% Owner
No longer subject to file 2013-06-03 0

WELLER HARRY R

  • 10% Owner
No longer subject to file 2013-06-03 0

VISWANATHAN RAVI

  • 10% Owner
No longer subject to file 2013-06-03 0

SANDELL SCOTT D

  • 10% Owner
No longer subject to file 2013-06-03 0

MOTT DAVID M

  • 10% Owner
No longer subject to file 2013-06-03 0

NEA PARTNERS 13, LIMITED PARTNERSHIP

NEA 13 GP, LTD

  • 10% Owner
No longer subject to file 2013-06-03 0

NEW ENTERPRISE ASSOCIATES 13 LP

  • 10% Owner
No longer subject to file 2013-06-03 0

REED JOHN C

  • Director
0 2012-06-14 0

DOMAIN PARTERS VII L P

  • 10% Owner
2,990,937 2011-11-21 0

DOVEY BRIAN H

  • 10% Owner
3,041,950 2011-11-21 0

HALAK BRIAN K

  • 10% Owner
3,041,950 2011-11-21 0

TREU JESSE I

  • 10% Owner
3,041,950 2011-11-21 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
3,041,950 2011-11-21 0

VITULLO NICOLE

  • 10% Owner
3,041,950 2011-11-21 0

DP VII ASSOCIATES LP

  • 10% Owner
51,013 2011-11-21 0

NEW ENTERPRISE ASSOCIATES 13 LP

NEA 13 GP, LTD

NEA PARTNERS 13, LIMITED PARTNERSHIP

  • 10% Owner
3,419,671 2011-11-21 0

KRAMLICH C RICHARD

  • 10% Owner
3,419,671 2011-11-21 0

DOMAIN ASSOCIATES

  • 10% Owner
32,758 2011-11-15 0

KAMDAR KIM P.

  • 10% Owner
32,758 2011-11-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-04 S 833 $5.54 d 729 direct -3.2423 -2.5597 0.0 1 -9.727 4

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-04 S 2,015 $5.54 d 71,098 direct -3.2423 -2.5597 0.0 1 -9.727 4

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-04 S 2,183 $5.54 d 47,312 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-04 S 1,448 $5.54 d 54,977 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-04 S 966 $5.54 d 1,575 direct -3.2423 -2.5597 0.0 1 -9.727 4

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-04 S 2,486 $5.54 d 73,237 direct -3.2423 -2.5597 0.0 1 -9.727 4

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-04 S 1,448 $5.54 d 48,931 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-04 S 2,183 $5.54 d 52,008 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-05-04 21:40:02 -0400 2021-05-04 S 80 $5.54 d 1,224 indirect -3.2423 -2.5597 0.0 1 -9.727 4

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-04 S 1,769 $5.54 d 247,059 direct -3.2423 -2.5597 0.0 1 -9.727 4

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-04 S 1,207 $5.54 d 44,870 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-04 S 1,206 $5.54 d 53,358 direct -3.2423 -2.5597 0.0 1 -9.727 4

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-04 S 2,183 $5.54 d 249,501 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-05-04 21:40:02 -0400 2021-05-01 M 181 a 1,304 indirect -3.2423 -2.5597 0.0 1 -9.727 4

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-01 M 3,749 a 248,828 direct -3.2423 -2.5597 0.0 1 -9.727 4

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-01 M 3,749 d 26,245 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-01 M 5,623 d 39,367 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-01 M 2,556 a 46,077 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-01 M 2,556 a 54,564 direct -3.2423 -2.5597 0.0 1 -9.727 4

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-01 M 4,625 d 50,875 direct

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-01 M 1,562 d 10,938 direct

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-01 M 4,625 a 251,684 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-01 M 1,562 a 1,562 direct -3.2423 -2.5597 0.0 1 -9.727 4

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-01 M 3,749 a 73,113 direct -3.2423 -2.5597 0.0 1 -9.727 4

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-01 M 4,625 a 49,495 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-01 M 4,625 d 50,875 direct

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-01 M 3,067 a 56,425 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS by wife

2021-05-04 21:40:02 -0400 2021-05-01 M 181 d 1,994 indirect

IVERS-READ GILLIAN C - Officer SEE REMARKS

2021-05-04 21:43:35 -0400 2021-05-01 M 3,749 d 26,245 direct

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-01 M 1,812 a 2,541 direct -3.2423 -2.5597 0.0 1 -9.727 4

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-01 M 4,625 d 50,875 direct

ROLFE LINDSEY - Officer SEE REMARKS

2021-05-04 21:39:22 -0400 2021-05-01 M 4,625 a 75,723 direct -3.2423 -2.5597 0.0 1 -9.727 4

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-01 M 4,625 d 50,875 direct

GROSS PAUL EDWARD - Officer SEE REMARKS

2021-05-04 21:39:01 -0400 2021-05-01 M 3,067 a 50,379 direct -3.2423 -2.5597 0.0 1 -9.727 4

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-01 M 5,623 d 39,367 direct

MUEHL DANIEL W - Officer SEE REMARKS

2021-05-04 21:40:31 -0400 2021-05-01 M 4,625 a 54,191 direct -3.2423 -2.5597 0.0 1 -9.727 4

HARDING THOMAS C. - Officer SEE REMARKS

2021-05-04 21:40:02 -0400 2021-05-01 M 1,812 d 19,938 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CLOVIS ONCOLOGY INC CLVS 2021-05-14 22:15:03 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 21:45:03 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 21:15:03 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 20:45:03 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 20:15:04 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 19:45:02 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 19:15:03 UTC -1.5479 1.5979 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 18:45:03 UTC -1.3771 1.4271 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 18:15:03 UTC -1.3771 1.4271 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 17:45:03 UTC -1.3771 1.4271 100000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 17:15:03 UTC -1.3771 1.4271 150000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 16:45:03 UTC -1.3717 1.4217 300000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 16:15:03 UTC -1.3717 1.4217 300000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 15:45:03 UTC -1.3717 1.4217 70000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 15:15:02 UTC -1.3717 1.4217 70000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 14:45:04 UTC -1.3954 1.4454 70000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 14:15:03 UTC -1.3954 1.4454 70000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 13:45:03 UTC -1.3954 1.4454 70000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 13:15:03 UTC -1.3954 1.4454 60000
CLOVIS ONCOLOGY INC CLVS 2021-05-14 12:45:03 UTC -1.3954 1.4454 50000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Multi-Strategy Alternative Fund CLVS -4996.0 shares, $-29126.68 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CLVS -32400.0 shares, $-227448.0 2021-03-31 N-PORT

Elevate your investments